This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Brooks Automation Management Presents At Morgan Stanley Technology, Media & Telecom Conference (Transcript)

Stocks in this article: BRKS

Brooks Automation (BRKS)

Morgan Stanley Technology, Media & Telecom Conference

Feb 29, 2012 04:00 PM ET


Martin Headley - CFO


Unidentified Analyst

Good afternoon everyone and thank you for coming. My name is Ms. Valerie and I'm member of the semiconductor and capital equipment equity research team here at Morgan Stanley. It's my pleasure to welcome Martin Headley, CFO of Brooks Automation. Martin is going to kick us off with some high level comments, opportunities for 2012 and then we'll jump into some Q&A.

Martin Headley

Thank you very much. I think it's best to frame what's top of mind with Brooks by maybe five significant priorities that we have at the moment. Firstly its integrating our new and very exciting Brooks Life Science Systems business into Brooks. This is a business that we entered with the acquisitions of RTF Life Sciences and Nexus Bio Systems during the course of 2011 and followed up with a very exciting product line acquisition of an automated Cytometer called Celigo in December of 2011 and this is a business that we see having a growth potential of over 20% per annum driven by personalized medicine initiatives that are really expanding the amount of biological samples that are being stored on this earth to facilitate those initiatives and we see the amount of samples being stored growing at somewhere between 25% and 30% per year and really being the fuel behind the driver for a fully effective sample management solution that will enable a better yield of the samples available from storage.

1 of 4

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,961.62 +156.82 0.88%
S&P 500 2,077.60 +6.95 0.34%
NASDAQ 4,778.9480 +13.5680 0.28%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs